This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: Delcath Systems, Inc., Other. Active years: 1998-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1998-2006
Title: The Innovative Contributions of Morton G. Glickman
Introduction
Morton G. Glickman is a distinguished inventor based in New Haven, CT, known for his significant contributions to medical technology. With an impressive portfolio of six patents, Glickman has dedicated his career to advancing treatment methods for glandular diseases and malignancies. His innovative approaches focus on enhancing the efficacy and safety of cancer treatments, showcasing his commitment to improving patient outcomes.
Latest Patents
Glickman's latest patents illustrate his groundbreaking work in the medical field. One notable patent describes a method for treating glandular diseases and malignancies. This method involves an in situ approach, where a diseased or malignant gland is treated by infusing a therapeutic agent into the blood flowing from it. By creating an isolated section for the contaminated blood, Glickman ensures that other organs and tissues are not exposed to the harmful substances during the treatment process.
Another significant innovation from Glickman is a cancer treatment method for specific organs, such as the kidney. This patent outlines a technique where a therapeutic agent is infused directly into the blood entering the diseased organ, while simultaneously capturing the contaminated effluent blood from tributary veins in an isolated section. The captured blood is then evacuated without disrupting overall circulation, thereby prioritizing the patient’s safety and health.
Career Highlights
Throughout his career, Morton G. Glickman has been associated with various companies, most notably Delcath Systems, Inc. His work with this organization has allowed him to explore and develop innovative medical treatments aimed at addressing complex glandular conditions.
Collaborations
In addition to his role at Delcath Systems, Inc., Glickman has collaborated with multiple entities within the field of medical research and development, further expanding his influence and impact on therapeutic advancements.
Conclusion
Morton G. Glickman's inventions reflect his deep understanding of complex medical issues and his dedication to finding effective solutions. With six patents to his name, Glickman exemplifies the spirit of innovation crucial to advancing healthcare. His contributions to the treatment of glandular diseases and malignancies serve as a testament to the potential of inventive thinking in improving medical practices and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile